389 related articles for article (PubMed ID: 34578464)
1. Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders.
Fattakhov N; Torices S; Stangis M; Park M; Toborek M
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578464
[TBL] [Abstract][Full Text] [Related]
2. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine augments HIV-1 gp120 inhibition of synaptic transmission and plasticity in rat hippocampal slices: Implications for methamphetamine exacerbation of HIV-associated neurocognitive disorders.
Zheng Y; Reiner B; Liu J; Xu L; Xiong H
Neurobiol Dis; 2022 Jun; 168():105712. PubMed ID: 35337950
[TBL] [Abstract][Full Text] [Related]
4. The combination of methamphetamine and of the HIV protein, Tat, induces death of the human neuroblastoma cell line, SH-SY5Y.
Cai NS; Cadet JL
Synapse; 2008 Jul; 62(7):551-2. PubMed ID: 18435425
[TBL] [Abstract][Full Text] [Related]
5. HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads.
Borgmann K; Ghorpade A
Front Microbiol; 2015; 6():1143. PubMed ID: 26579077
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine, the brain, HIV, and mental health.
Jones K
Focus; 2005 Jul; 20(6):1-5. PubMed ID: 16110566
[No Abstract] [Full Text] [Related]
7. Mitochondrial injury and cognitive function in HIV infection and methamphetamine use.
Var SR; Day TR; Vitomirov A; Smith DM; Soontornniyomkij V; Moore DJ; Achim CL; Mehta SR; Pérez-Santiago J
AIDS; 2016 Mar; 30(6):839-48. PubMed ID: 26807965
[TBL] [Abstract][Full Text] [Related]
8. Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence.
Pocuca N; Young JW; MacQueen DA; Letendre S; Heaton RK; Geyer MA; Perry W; Grant I; Minassian A;
Drug Alcohol Depend; 2020 Oct; 215():108245. PubMed ID: 32871507
[TBL] [Abstract][Full Text] [Related]
9. HIV and chronic methamphetamine dependence affect cerebral blood flow.
Ances BM; Vaida F; Cherner M; Yeh MJ; Liang CL; Gardner C; Grant I; Ellis RJ; Buxton RB;
J Neuroimmune Pharmacol; 2011 Sep; 6(3):409-19. PubMed ID: 21431471
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine and HIV-Tat Protein Synergistically Induce Oxidative Stress and Blood-Brain Barrier Damage via Transient Receptor Potential Melastatin 2 Channel.
Huang J; Zhang R; Wang S; Zhang D; Leung CK; Yang G; Li Y; Liu L; Xu Y; Lin S; Wang C; Zeng X; Li J
Front Pharmacol; 2021; 12():619436. PubMed ID: 33815104
[TBL] [Abstract][Full Text] [Related]
11. Patterns of selective neuronal damage in methamphetamine-user AIDS patients.
Langford D; Adame A; Grigorian A; Grant I; McCutchan JA; Ellis RJ; Marcotte TD; Masliah E;
J Acquir Immune Defic Syndr; 2003 Dec; 34(5):467-74. PubMed ID: 14657756
[TBL] [Abstract][Full Text] [Related]
12. Region-specific changes in markers of neuroplasticity revealed in HIV-1 transgenic rats by low-dose methamphetamine.
Ohene-Nyako M; Persons AL; Napier TC
Brain Struct Funct; 2018 Sep; 223(7):3503-3513. PubMed ID: 29931627
[TBL] [Abstract][Full Text] [Related]
13. Multiple Faceted Roles of Cocaine in Potentiation of HAND.
Cai Y; Yang L; Callen S; Buch S
Curr HIV Res; 2016; 14(5):412-416. PubMed ID: 27009095
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine.
Cherner M; Letendre S; Heaton RK; Durelle J; Marquie-Beck J; Gragg B; Grant I;
Neurology; 2005 Apr; 64(8):1343-7. PubMed ID: 15851720
[TBL] [Abstract][Full Text] [Related]
15. The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis.
Passaro RC; Pandhare J; Qian HZ; Dash C
J Neuroimmune Pharmacol; 2015 Sep; 10(3):477-86. PubMed ID: 25850893
[TBL] [Abstract][Full Text] [Related]
16. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus.
Bowyer JF; Ali S
Synapse; 2006 Dec; 60(7):521-32. PubMed ID: 16952162
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine and HIV-1 Tat down regulate β-catenin signaling: implications for methampetamine abuse and HIV-1 co-morbidity.
Sharma A; Hu XT; Napier TC; Al-Harthi L
J Neuroimmune Pharmacol; 2011 Dec; 6(4):597-607. PubMed ID: 21744004
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.
Saloner R; Fields JA; Marcondes MCG; Iudicello JE; von Känel S; Cherner M; Letendre SL; Kaul M; Grant I;
J Neuroimmune Pharmacol; 2020 Dec; 15(4):743-764. PubMed ID: 32929575
[TBL] [Abstract][Full Text] [Related]
19. Overview of blood-brain barrier dysfunction in methamphetamine abuse.
Pang L; Wang Y
Biomed Pharmacother; 2023 May; 161():114478. PubMed ID: 37002574
[TBL] [Abstract][Full Text] [Related]
20. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
Hong S; Banks WA
Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
